These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 11976797)
1. Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results. Gotthardt M; Fischer M; Naeher I; Holz JB; Jungclas H; Fritsch HW; Béhé M; Göke B; Joseph K; Behr TM Eur J Nucl Med Mol Imaging; 2002 May; 29(5):597-606. PubMed ID: 11976797 [TBL] [Abstract][Full Text] [Related]
2. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746 [TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes. Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327 [TBL] [Abstract][Full Text] [Related]
4. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143 [TBL] [Abstract][Full Text] [Related]
5. Internalization of glucagon-like peptide-1(7-36)amide in rat insulinoma cells. Göke R; Richter G; Göke B; Trautmann M; Arnold R Res Exp Med (Berl); 1989; 189(4):257-64. PubMed ID: 2554438 [TBL] [Abstract][Full Text] [Related]
6. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET. Brom M; Oyen WJ; Joosten L; Gotthardt M; Boerman OC Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1345-55. PubMed ID: 20111963 [TBL] [Abstract][Full Text] [Related]
7. Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake. Läppchen T; Tönnesmann R; Eersels J; Meyer PT; Maecke HR; Rylova SN PLoS One; 2017; 12(1):e0170435. PubMed ID: 28103285 [TBL] [Abstract][Full Text] [Related]
8. Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding. Jehle PM; Jehle D; Fussgänger RD; Adler G Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():31-6. PubMed ID: 8839251 [TBL] [Abstract][Full Text] [Related]
9. Value of the radiolabelled GLP-1 receptor antagonist exendin(9-39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans. Waser B; Reubi JC Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1054-8. PubMed ID: 21210113 [TBL] [Abstract][Full Text] [Related]
10. Interaction of glucagon-like peptide-1(7-36)amide and somatostatin-14 in RINm5F cells and in the perfused rat pancreas. Göke R; Fehmann HC; Richter G; Trautmann M; Göke B Pancreas; 1989; 4(6):668-73. PubMed ID: 2573056 [TBL] [Abstract][Full Text] [Related]
11. Development of Kimura H; Matsuda H; Ogawa Y; Fujimoto H; Toyoda K; Fujita N; Arimitsu K; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H Bioorg Med Chem; 2017 Feb; 25(4):1406-1412. PubMed ID: 28089587 [TBL] [Abstract][Full Text] [Related]
12. Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes. Lankat-Buttgereit B; Göke R; Stöckmann F; Jiang J; Fehmann HC; Göke B Digestion; 1994; 55(1):29-33. PubMed ID: 8112494 [TBL] [Abstract][Full Text] [Related]
13. [ Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071 [TBL] [Abstract][Full Text] [Related]
14. [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. Wicki A; Wild D; Storch D; Seemayer C; Gotthardt M; Behe M; Kneifel S; Mihatsch MJ; Reubi JC; Mäcke HR; Christofori G Clin Cancer Res; 2007 Jun; 13(12):3696-705. PubMed ID: 17575235 [TBL] [Abstract][Full Text] [Related]
15. PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue. Gao H; Niu G; Yang M; Quan Q; Ma Y; Murage EN; Ahn JM; Kiesewetter DO; Chen X Mol Pharm; 2011 Oct; 8(5):1775-82. PubMed ID: 21800885 [TBL] [Abstract][Full Text] [Related]
17. 18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals. Wu H; Liang S; Liu S; Pan Y; Cheng D; Zhang Y Nucl Med Commun; 2013 Jul; 34(7):701-8. PubMed ID: 23652208 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma Diagnosis. Faintuch BL; Seo D; de Oliveira EA; Targino RC; Moro AM Curr Radiopharm; 2017; 10(1):65-72. PubMed ID: 28164753 [TBL] [Abstract][Full Text] [Related]
19. Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys Senica K; Tomazic A; Skvarca A; Kolenc Peitl P; Mikolajczak R; Hubalewska-Dydejczyk A; Lezaic L Mol Imaging Biol; 2020 Feb; 22(1):165-172. PubMed ID: 31098984 [TBL] [Abstract][Full Text] [Related]
20. Solubilization of active GLP-1 (7-36)amide receptors from RINm5F plasma membranes. Göke R; Oltmer B; Sheikh SP; Göke B FEBS Lett; 1992 Apr; 300(3):232-6. PubMed ID: 1313374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]